SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001493152-19-011639
Filing Date
2019-08-05
Accepted
2019-08-05 17:29:38
Documents
1
Period of Report
2019-03-14

Document Format Files

Seq Description Document Type Size
1 ownership.html 3/A  
1 ownership.xml 3/A 2238
  Complete submission text file 0001493152-19-011639.txt   3836
Mailing Address 1801 CENTURY PARK EAST 24TH FLOOR LOS ANGELES CA 90067
Business Address 1801 CENTURY PARK EAST 24TH FLOOR LOS ANGELES CA 90067 424 772 2191
Hoverink Biotechnologies, Inc. (Issuer) CIK: 0001586494 (see all company filings)

IRS No.: 463590875 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10250 CONSTELLATION BLVD SUITE 2300 CENTURY CITY CA 90067
Business Address
Sajna Davidra Nicole (Reporting) CIK: 0001653739 (see all company filings)

Type: 3/A | Act: 34 | File No.: 000-55055 | Film No.: 19999742